Literature DB >> 24599133

Contributions of the host microenvironment to cancer-induced bone disease.

Sam W Z Olechnowicz1, Claire M Edwards.   

Abstract

The bone marrow provides a specialized and highly supportive microenvironment for tumor growth and development of the associated bone disease. It is a preferred site for breast and prostate cancer bone metastasis and the hematologic malignancy, multiple myeloma. For many years, researchers have focused upon the interactions between tumor cells and the cells directly responsible for bone remodeling, namely osteoclasts and osteoblasts. However, there is ever-increasing evidence for a multitude of ways in which the bone marrow microenvironment can promote disease pathogenesis, including via cancer-associated fibroblasts, the hematopoietic stem cell niche, myeloid-derived suppressor cells, and the sympathetic nervous system. This review discusses the recent advances in our understanding of the contribution of the host microenvironment to the development of cancer-induced bone disease. ©2014 AACR.

Entities:  

Mesh:

Year:  2014        PMID: 24599133      PMCID: PMC3966188          DOI: 10.1158/0008-5472.CAN-13-2645

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  86 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

Review 2.  Tumor-induced immune dysfunctions caused by myeloid suppressor cells.

Authors:  V Bronte; P Serafini; E Apolloni; P Zanovello
Journal:  J Immunother       Date:  2001 Nov-Dec       Impact factor: 4.456

3.  Hypoxia increases VEGF-A production by prostate cancer and bone marrow stromal cells and initiates paracrine activation of bone marrow endothelial cells.

Authors:  Caroline Muir; Leland W K Chung; Daniel D Carson; Mary C Farach-Carson
Journal:  Clin Exp Metastasis       Date:  2006-07-07       Impact factor: 5.150

4.  Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease.

Authors:  Sonia Vallet; Siddhartha Mukherjee; Nileshwari Vaghela; Teru Hideshima; Mariateresa Fulciniti; Samantha Pozzi; Loredana Santo; Diana Cirstea; Kishan Patel; Aliyah R Sohani; Alex Guimaraes; Wanling Xie; Dharminder Chauhan; Jesse A Schoonmaker; Eyal Attar; Michael Churchill; Edie Weller; Nikhil Munshi; Jasbir S Seehra; Ralph Weissleder; Kenneth C Anderson; David T Scadden; Noopur Raje
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

5.  CXCR4 regulates growth of both primary and metastatic breast cancer.

Authors:  Matthew C P Smith; Kathryn E Luker; Joel R Garbow; Julie L Prior; Erin Jackson; David Piwnica-Worms; Gary D Luker
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

6.  Depression induces bone loss through stimulation of the sympathetic nervous system.

Authors:  Raz Yirmiya; Inbal Goshen; Alon Bajayo; Tirzah Kreisel; Sharon Feldman; Joseph Tam; Victoria Trembovler; Valér Csernus; Esther Shohami; Itai Bab
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

Review 7.  Cancer associated fibroblasts in cancer pathogenesis.

Authors:  Omar E Franco; Aubie K Shaw; Douglas W Strand; Simon W Hayward
Journal:  Semin Cell Dev Biol       Date:  2009-11-05       Impact factor: 7.727

8.  Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis.

Authors:  Younghun Jung; Jin Koo Kim; Yusuke Shiozawa; Jingcheng Wang; Anjali Mishra; Jeena Joseph; Janice E Berry; Samantha McGee; Eunsohl Lee; Hongli Sun; Jianhua Wang; Taocong Jin; Honglai Zhang; Jinlu Dai; Paul H Krebsbach; Evan T Keller; Kenneth J Pienta; Russell S Taichman
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

9.  Computational modeling of interactions between multiple myeloma and the bone microenvironment.

Authors:  Yan Wang; Peter Pivonka; Pascal R Buenzli; David W Smith; Colin R Dunstan
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

10.  CXCR4 is required for the quiescence of primitive hematopoietic cells.

Authors:  Yuchun Nie; Yoon-Chi Han; Yong-Rui Zou
Journal:  J Exp Med       Date:  2008-03-31       Impact factor: 14.307

View more
  43 in total

Review 1.  The bone-marrow niche in MDS and MGUS: implications for AML and MM.

Authors:  Irene M Ghobrial; Alexandre Detappe; Kenneth C Anderson; David P Steensma
Journal:  Nat Rev Clin Oncol       Date:  2018-01-09       Impact factor: 66.675

Review 2.  Pathogenesis beyond the cancer clone(s) in multiple myeloma.

Authors:  Giada Bianchi; Nikhil C Munshi
Journal:  Blood       Date:  2015-04-02       Impact factor: 22.113

Review 3.  Tissue-engineered models of human tumors for cancer research.

Authors:  Aranzazu Villasante; Gordana Vunjak-Novakovic
Journal:  Expert Opin Drug Discov       Date:  2015-02-07       Impact factor: 6.098

Review 4.  Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease.

Authors:  Michelle M McDonald; Jesus Delgado-Calle
Journal:  Curr Osteoporos Rep       Date:  2017-12       Impact factor: 5.096

Review 5.  Molecular alterations that drive breast cancer metastasis to bone.

Authors:  Penelope D Ottewell; Liam O'Donnell; Ingunn Holen
Journal:  Bonekey Rep       Date:  2015-03-18

Review 6.  Dynamic interplay between bone and multiple myeloma: emerging roles of the osteoblast.

Authors:  Michaela R Reagan; Lucy Liaw; Clifford J Rosen; Irene M Ghobrial
Journal:  Bone       Date:  2015-02-26       Impact factor: 4.398

Review 7.  The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease.

Authors:  Christina J Turner; Claire M Edwards
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

Review 8.  Skeletal complications in cancer patients with bone metastases.

Authors:  Shunsuke Tsuzuki; Sun Hee Park; Matthew R Eber; Christopher M Peters; Yusuke Shiozawa
Journal:  Int J Urol       Date:  2016-08-03       Impact factor: 3.369

Review 9.  The emerging role of bone marrow adipose tissue in bone health and dysfunction.

Authors:  Thomas H Ambrosi; Tim J Schulz
Journal:  J Mol Med (Berl)       Date:  2017-11-03       Impact factor: 4.599

10.  Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer.

Authors:  Isaac M Adjei; Blanka Sharma; Chiranjeevi Peetla; Vinod Labhasetwar
Journal:  J Control Release       Date:  2016-04-15       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.